Inovio Pharmaceuticals's three largest insider shareholders as of September 29, 2026 are Jacqueline Elizabeth Shea (Chief Executive Officer, 111.02K shares), David B. Weiner (Director, 87.59K shares), Laurent Humeau (Chief Scientific Officer, 46.82K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jacqueline Elizabeth Shea | Chief Executive Officer | 111,021 | 0 | 111,021 | 28.0% | 21 May, 2026 |
| 2 | David B. Weiner | Director | 87,592 | 0 | 87,592 | 22.1% | 27 Feb, 2026 |
| 3 | Laurent Humeau | Chief Scientific Officer | 46,823 | 0 | 46,823 | 11.8% | 21 May, 2026 |
| 4 | Peter Kies | Cfo | 42,854 | 0 | 42,854 | 10.8% | 21 May, 2026 |
| 5 | Michael John Sumner | Chief Medical Officer | 42,038 | 0 | 42,038 | 10.6% | 21 May, 2026 |
| 6 | Simon X Benito | Director | 12,191 | 0 | 12,191 | 3.1% | 21 May, 2025 |
| 7 | Wendy L Yarno | Director | 10,512 | 0 | 10,512 | 2.6% | 21 May, 2025 |
| 8 | Ann Calby Miller | Director | 9,877 | 0 | 9,877 | 2.5% | 21 May, 2025 |
| 9 | Jay Shepard | Director | 9,209 | 0 | 9,209 | 2.3% | 21 May, 2025 |
| 10 | Roger D Dansey | Director | 8,916 | 0 | 8,916 | 2.2% | 21 May, 2025 |
| 11 | Lota S. Zoth | Director | 8,726 | 0 | 8,726 | 2.2% | 21 May, 2025 |
| 12 | Jong Joseph Kim | Chief Executive Officer | 7,409 | 0 | 7,409 | 1.9% | 14 Mar, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 20 May, 2026 | Wendy L Yarno | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | Ann Calby Miller | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | Lota S. Zoth | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | Jay Shepard | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | Peter Kies | Cfo | Acquired M | 8,700 | — | — | 47,542 | Direct |
| 20 May, 2026 | Roger D Dansey | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | David B. Weiner | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | Michael John Sumner | Chief Medical Officer | Acquired M | 9,450 | — | — | 44,731 | Direct |
| 20 May, 2026 | Laurent Humeau | Chief Scientific Officer | Acquired M | 6,027 | — | — | 48,986 | Direct |
| 20 May, 2026 | Simon X Benito | Director | Acquired A | 41,800 | $0.00 | $0 | 41,800 | Direct |
| 20 May, 2026 | Jacqueline Elizabeth Shea | Chief Executive Officer | Acquired M | 28,296 | — | — | 123,327 | Direct |
| 20 May, 2026 | Roger D Dansey | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | David B. Weiner | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | Peter Kies | Cfo | Disposed F | 4,688 | $1.23 | $5.77K | 42,854 | Direct |
| 20 May, 2026 | Simon X Benito | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | Ann Calby Miller | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | Wendy L Yarno | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | Jay Shepard | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | Lota S. Zoth | Director | Acquired A | 34,200 | $0.00 | $0 | 34,200 | Direct |
| 20 May, 2026 | Laurent Humeau | Chief Scientific Officer | Disposed F | 2,163 | $1.23 | $2.66K | 46,823 | Direct |